Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1540996
PUBLISHER: IMARC | PRODUCT CODE: 1540996
Multiple Myeloma Drugs Market Report by Therapy, Drug Type, End-User, Distribution Channel, and Region 2024-2032
PUBLISHED:
PAGES: 138 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global multiple myeloma drugs market size reached US$ 22.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 35.5 Billion by 2032, exhibiting a growth rate (CAGR) of 5.2% during 2024-2032.
Multiple myeloma, or Kahler's disease, refers to a form of blood cancer that primarily affects the plasma cells. Some of the most common types of multiple myeloma drugs include chemotherapeutic agents, corticosteroids and immunomodulatory agents. These pharmaceutical drugs aid in promoting bone healing, prevent hypercalcemia, bone fracture, spinal cord compression and anemia, while minimizing the need for chemotherapy. The chemotherapeutic agents include various anthracycline antibiotics and alkylating agents, such as melphalan, doxorubicin, vincristine and liposomal doxorubicin. The targeted therapy drugs include proteasome inhibitor, such as bortezomib, and various other compounds, including dexamethasone, prednisone and thalidomide.
Significant developments in the healthcare sector, along with the increasing prevalence of hematological cancer, is one of the key factors driving the growth of the market. Multiple myeloma is usually caused by specific genetic abnormalities, and the treatment of this disease involves drugs that modulate the immune system and aid in enhancing the efficiency of chemotherapies, radiation therapies, stem cell transplants and platelet transfusion. Furthermore, rising consumer awareness regarding the benefits of biologic therapy drugs, which utilize the body's immune system to identify and attack the myeloma cells, is also providing a boost to the market growth. Additionally, various technological advancements, such as the development of microRNA therapeutics and nanomedicines for the treatment of multiple myeloma, is acting as another growth-inducing factor. These medicines are used to facilitate the delivery of macromolecular agents into the bone marrow and catalyze antitumor responses. Other factors, including the rising healthcare expenditures and extensive research and development (R&D) activities in the field of medical sciences, are projected to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global multiple myeloma drugs market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on therapy, drug type, end-user and distribution channel.
Breakup by Therapy:
Targeted Therapy
Biologic Therapy
Chemotherapy
Others
Breakup by Drug Type:
Immunomodulatory Drugs
Proteasome Inhibitors
Histone Deacetylase Inhibitors
Monoclonal Antibody Drugs
Steroids
Others
Breakup by End-User:
Men
Women
Breakup by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Amgen Inc., Bristol Myers Squibb, Daiichi Sankyo Co., Ltd., Sanofi-Aventis Groupe (Genzyme Corporation), Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis International AG, Pfizer Inc., PHARMA MAR, S.A., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., etc.
Key Questions Answered in This Report:
- How has the global multiple myeloma drugs market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What has been the impact of COVID-19 on the global multiple myeloma drugs market?
- What is the breakup of the market based on the therapy?
- What is the breakup of the market based on the drug type?
- What is the breakup of the market based on the end-user?
- What is the breakup of the market based on the distribution channel?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global multiple myeloma drugs market and who are the key players?
- What is the degree of competition in the industry?
Product Code: SR112024A2169
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Pipeline Assesment/Clinical Trial Products/Clinical Developments
- 5.1 PegIntron (Pegylated interferon alfa-2b)
- 5.2 Pomalidomide
- 5.3 Tanespimycin (KOS-953)
- 5.4 MLN 9708
- 5.5 SRT-501- 012
- 5.6 BHQ880
- 5.7 Panobinostat
- 5.8 ZIO-101
- 5.9 VEGF-Trap(Aflibercept)
- 5.10 Denosumab
- 5.11 Perifosine
- 5.12 Actimid (CC-5013)
- 5.13 Romidepsin
- 5.14 Plitidepsin (Aplidin)
- 5.15 Temsirolimus (Torisel)
- 5.16 Sorafenib
- 5.17 Bevacizumab
6 Global Multiple Myeloma Drugs Market
- 6.1 Market Overview
- 6.2 Market Performance
- 6.3 Impact of COVID-19
- 6.4 Market Forecast
7 Market Breakup by Therapy
- 7.1 Targeted Therapy
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Biologic Therapy
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Chemotherapy
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by Drug Type
- 8.1 Immunomodulatory Drugs
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Proteasome Inhibitors
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Histone Deacetylase Inhibitors
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Monoclonal Antibody Drugs
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Steroids
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
- 8.6 Others
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
9 Market Breakup by End-User
- 9.1 Men
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Women
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
10 Market Breakup by Distribution Channel
- 10.1 Hospital Pharmacies
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
- 10.2 Retail Pharmacies
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
- 10.3 Online Pharmacies
- 10.3.1 Market Trends
- 10.3.2 Market Forecast
- 10.4 Others
- 10.4.1 Market Trends
- 10.4.2 Market Forecast
11 Market Breakup by Region
- 11.1 North America
- 11.1.1 United States
- 11.1.1.1 Market Trends
- 11.1.1.2 Market Forecast
- 11.1.2 Canada
- 11.1.2.1 Market Trends
- 11.1.2.2 Market Forecast
- 11.1.1 United States
- 11.2 Asia Pacific
- 11.2.1 China
- 11.2.1.1 Market Trends
- 11.2.1.2 Market Forecast
- 11.2.2 Japan
- 11.2.2.1 Market Trends
- 11.2.2.2 Market Forecast
- 11.2.3 India
- 11.2.3.1 Market Trends
- 11.2.3.2 Market Forecast
- 11.2.4 South Korea
- 11.2.4.1 Market Trends
- 11.2.4.2 Market Forecast
- 11.2.5 Australia
- 11.2.5.1 Market Trends
- 11.2.5.2 Market Forecast
- 11.2.6 Indonesia
- 11.2.6.1 Market Trends
- 11.2.6.2 Market Forecast
- 11.2.7 Others
- 11.2.7.1 Market Trends
- 11.2.7.2 Market Forecast
- 11.2.1 China
- 11.3 Europe
- 11.3.1 Germany
- 11.3.1.1 Market Trends
- 11.3.1.2 Market Forecast
- 11.3.2 France
- 11.3.2.1 Market Trends
- 11.3.2.2 Market Forecast
- 11.3.3 United Kingdom
- 11.3.3.1 Market Trends
- 11.3.3.2 Market Forecast
- 11.3.4 Italy
- 11.3.4.1 Market Trends
- 11.3.4.2 Market Forecast
- 11.3.5 Spain
- 11.3.5.1 Market Trends
- 11.3.5.2 Market Forecast
- 11.3.6 Russia
- 11.3.6.1 Market Trends
- 11.3.6.2 Market Forecast
- 11.3.7 Others
- 11.3.7.1 Market Trends
- 11.3.7.2 Market Forecast
- 11.3.1 Germany
- 11.4 Latin America
- 11.4.1 Brazil
- 11.4.1.1 Market Trends
- 11.4.1.2 Market Forecast
- 11.4.2 Mexico
- 11.4.2.1 Market Trends
- 11.4.2.2 Market Forecast
- 11.4.3 Others
- 11.4.3.1 Market Trends
- 11.4.3.2 Market Forecast
- 11.4.1 Brazil
- 11.5 Middle East and Africa
- 11.5.1 Market Trends
- 11.5.2 Market Breakup by Country
- 11.5.3 Market Forecast
12 SWOT Analysis
- 12.1 Overview
- 12.2 Strengths
- 12.3 Weaknesses
- 12.4 Opportunities
- 12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
- 14.1 Overview
- 14.2 Bargaining Power of Buyers
- 14.3 Bargaining Power of Suppliers
- 14.4 Degree of Competition
- 14.5 Threat of New Entrants
- 14.6 Threat of Substitutes
15 Price Indicators
16 Competitive Landscape
- 16.1 Market Structure
- 16.2 Key Players
- 16.3 Profiles of Key Players
- 16.3.1 Amgen Inc.
- 16.3.1.1 Company Overview
- 16.3.1.2 Product Portfolio
- 16.3.1.3 Financials
- 16.3.1.4 SWOT Analysis
- 16.3.2 Bristol Myers Squibb
- 16.3.2.1 Company Overview
- 16.3.2.2 Product Portfolio
- 16.3.2.3 Financials
- 16.3.2.4 SWOT Analysis
- 16.3.3 Daiichi Sankyo Co.
- 16.3.3.1 Company Overview
- 16.3.3.2 Product Portfolio
- 16.3.3.3 Financials
- 16.3.3.4 SWOT Analysis
- 16.3.4 Sanofi-Aventis Groupe (Genzyme Corporation)
- 16.3.4.1 Company Overview
- 16.3.4.2 Product Portfolio
- 16.3.4.3 SWOT Analysis
- 16.3.5 Johnson & Johnson Services, Inc.
- 16.3.5.1 Company Overview
- 16.3.5.2 Product Portfolio
- 16.3.5.3 Financials
- 16.3.5.4 SWOT Analysis
- 16.3.6 Merck & Co., Inc.
- 16.3.6.1 Company Overview
- 16.3.6.2 Product Portfolio
- 16.3.6.3 Financials
- 16.3.6.4 SWOT Analysis
- 16.3.7 Novartis International AG
- 16.3.7.1 Company Overview
- 16.3.7.2 Product Portfolio
- 16.3.7.3 Financials
- 16.3.7.4 SWOT Analysis
- 16.3.8 Pfizer Inc.
- 16.3.8.1 Company Overview
- 16.3.8.2 Product Portfolio
- 16.3.8.3 Financials
- 16.3.8.4 SWOT Analysis
- 16.3.9 PHARMA MAR, S.A.
- 16.3.9.1 Company Overview
- 16.3.9.2 Product Portfolio
- 16.3.9.3 Financials
- 16.3.10 Takeda Pharmaceutical Company Limited.
- 16.3.10.1 Company Overview
- 16.3.10.2 Product Portfolio
- 16.3.10.3 Financials
- 16.3.10.4 SWOT Analysis
- 16.3.11 Teva Pharmaceutical Industries Ltd.
- 16.3.11.1 Company Overview
- 16.3.11.2 Product Portfolio
- 16.3.11.3 Financials
- 16.3.11.4 SWOT Analysis
- 16.3.1 Amgen Inc.
Product Code: SR112024A2169
List of Figures
- Figure 1: Global: Multiple Myeloma Drugs Market: Major Drivers and Challenges
- Figure 2: Global: Multiple Myeloma Drugs Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Multiple Myeloma Drugs Market: Breakup by Therapy (in %), 2023
- Figure 4: Global: Multiple Myeloma Drugs Market: Breakup by Drug Type (in %), 2023
- Figure 5: Global: Multiple Myeloma Drugs Market: Breakup by End-User (in %), 2023
- Figure 6: Global: Multiple Myeloma Drugs Market: Breakup by Distribution Channel (in %), 2023
- Figure 7: Global: Multiple Myeloma Drugs Market: Breakup by Region (in %), 2023
- Figure 8: Global: Multiple Myeloma Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 9: Global: Multiple Myeloma Drugs (Targeted Therapy) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 10: Global: Multiple Myeloma Drugs (Targeted Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 11: Global: Multiple Myeloma Drugs (Biologic Therapy) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 12: Global: Multiple Myeloma Drugs (Biologic Therapy) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 13: Global: Multiple Myeloma Drugs (Chemotherapy) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 14: Global: Multiple Myeloma Drugs (Chemotherapy) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 15: Global: Multiple Myeloma Drugs (Others) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 16: Global: Multiple Myeloma Drugs (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 17: Global: Multiple Myeloma Drugs (Immunomodulatory Drugs) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 18: Global: Multiple Myeloma Drugs (Immunomodulatory Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 19: Global: Multiple Myeloma Drugs (Proteasome Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 20: Global: Multiple Myeloma Drugs (Proteasome Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 21: Global: Multiple Myeloma Drugs (Histone Deacetylase Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 22: Global: Multiple Myeloma Drugs (Histone Deacetylase Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 23: Global: Multiple Myeloma Drugs (Monoclonal Antibody Drugs) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 24: Global: Multiple Myeloma Drugs (Monoclonal Antibody Drugs) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 25: Global: Multiple Myeloma Drugs (Steroids) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 26: Global: Multiple Myeloma Drugs (Steroids) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 27: Global: Multiple Myeloma Drugs (Others) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 28: Global: Multiple Myeloma Drugs (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 29: Global: Multiple Myeloma Drugs (Men) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 30: Global: Multiple Myeloma Drugs (Men) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 31: Global: Multiple Myeloma Drugs (Women) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 32: Global: Multiple Myeloma Drugs (Women) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 33: Global: Multiple Myeloma Drugs (Hospital Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 34: Global: Multiple Myeloma Drugs (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 35: Global: Multiple Myeloma Drugs (Retail Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 36: Global: Multiple Myeloma Drugs (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 37: Global: Multiple Myeloma Drugs (Online Pharmacies) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 38: Global: Multiple Myeloma Drugs (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 39: Global: Multiple Myeloma Drugs (Others) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 40: Global: Multiple Myeloma Drugs (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 41: North America: Multiple Myeloma Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 42: North America: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 43: United States: Multiple Myeloma Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 44: United States: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 45: Canada: Multiple Myeloma Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 46: Canada: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 47: Asia Pacific: Multiple Myeloma Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 48: Asia Pacific: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 49: China: Multiple Myeloma Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 50: China: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 51: Japan: Multiple Myeloma Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 52: Japan: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 53: India: Multiple Myeloma Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 54: India: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 55: South Korea: Multiple Myeloma Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 56: South Korea: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 57: Australia: Multiple Myeloma Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 58: Australia: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 59: Indonesia: Multiple Myeloma Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 60: Indonesia: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 61: Others: Multiple Myeloma Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 62: Others: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 63: Europe: Multiple Myeloma Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 64: Europe: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 65: Germany: Multiple Myeloma Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 66: Germany: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 67: France: Multiple Myeloma Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 68: France: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 69: United Kingdom: Multiple Myeloma Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 70: United Kingdom: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 71: Italy: Multiple Myeloma Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 72: Italy: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 73: Spain: Multiple Myeloma Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 74: Spain: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 75: Russia: Multiple Myeloma Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 76: Russia: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 77: Others: Multiple Myeloma Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 78: Others: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 79: Latin America: Multiple Myeloma Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 80: Latin America: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 81: Brazil: Multiple Myeloma Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 82: Brazil: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 83: Mexico: Multiple Myeloma Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 84: Mexico: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 85: Others: Multiple Myeloma Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 86: Others: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 87: Middle East and Africa: Multiple Myeloma Drugs Market: Sales Value (in Million US$), 2018 & 2023
- Figure 88: Middle East and Africa: Multiple Myeloma Drugs Market: Breakup by Country (in %), 2023
- Figure 89: Middle East and Africa: Multiple Myeloma Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 90: Global: Multiple Myeloma Drugs Industry: SWOT Analysis
- Figure 91: Global: Multiple Myeloma Drugs Industry: Value Chain Analysis
- Figure 92: Global: Multiple Myeloma Drugs Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Multiple Myeloma Drugs Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Multiple Myeloma Drugs Market Forecast: Breakup by Therapy (in Million US$), 2024-2032
- Table 3: Global: Multiple Myeloma Drugs Market Forecast: Breakup by Drug Type (in Million US$), 2024-2032
- Table 4: Global: Multiple Myeloma Drugs Market Forecast: Breakup by End-User (in Million US$), 2024-2032
- Table 5: Global: Multiple Myeloma Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
- Table 6: Global: Multiple Myeloma Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 7: Global: Multiple Myeloma Drugs Market Structure
- Table 8: Global: Multiple Myeloma Drugs Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.